BeuteJ, BoermansP, BenraadB, TelmanJ, DiamantZ, and KleinJanA: PDE3-inhibitor enoximone prevented mechanical ventilation in patients with SARS-CoV-2 pneumonia. Exp Lung Res. 2021; 47:149–160.
2.
GiorgiM, CardarelliS, RagusaF, SaliolaM, BiagioniS, PoianaG, NaroF, and MassimiM: Phosphodiesterase inhibitors: Could they be beneficial for the treatment of COVID-19?. Int J Mol Sci. 2020; 21:5338.
3.
BeuteJ, and KleinJanA: Oral enoximone allows the reduction and discontinuation of inhaled steroids and beta2 agonists in asthmatic children. Int J Pediatr Adolesc Med. 2021. [Epub ahead of print]; DOI:10.1016/j.ijpam.2021.02.002.
4.
BeuteJ. Emergency treatment of status asthmaticus with enoximone. Br J Anaesth. 2014; 112:1105–1108.
5.
OkerholmRA, ChanKY, and LangJF, ThompsonGA, RubergSJ: Biotransformation and pharmacokinetic overview of enoximone and its sulfoxide metabolite. Am J Cardiol. 1987; 60:21C–26C.
